1.
Ghouse J, Ahlberg G, Rand SA, et al. Potential Influence of Risk Factor Control on the Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease. Arteriosclerosis, thrombosis, and vascular biology. 2024. doi:10.1161/ATVBAHA.124.320990.
1.
Singh SD, Senff JR, van Duijn CM, Rosand J. Treating Hypertension: Important for Heart Health, Fundamental for Brain Health. Stroke. 2024. doi:10.1161/STROKEAHA.123.046179.
1.
Hasbani NR, Westerman KE, Kwak SH, et al. Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis. Circulation. Genomic and precision medicine. 2023;16(6):e004176. doi:10.1161/CIRCGEN.123.004176.
1.
Oh J, Kim M, Rhee SY, et al. National Trends in the Prevalence of Screen Time and Its Association With Biopsychosocial Risk Factors Among Korean Adolescents, 2008-2021. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2023. doi:10.1016/j.jadohealth.2023.10.021.
1.
Singh SD, Oreskovic T, Carr S, et al. The predictive validity of a Brain Care Score for dementia and stroke: data from the UK Biobank cohort. Frontiers in neurology. 2023;14:1291020. doi:10.3389/fneur.2023.1291020.
1.
Dreier JW, Pedersen CB, Cotsapas C, Christensen J. Childhood seizures and risk of psychiatric disorders in adolescence and early adulthood: a Danish nationwide cohort study. Lancet Child Adolesc Health. 2019;3(2):99-108. doi:10.1016/S2352-4642(18)30351-1.
1.
Carr PR, Banbury BL, Berndt SI, et al. Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis. Clin Gastroenterol Hepatol. 2019;17(8):1561-1570.e3. doi:10.1016/j.cgh.2018.11.036.
1.
Huyghe JR, Bien SA, Harrison TA, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51(1):76-87. doi:10.1038/s41588-018-0286-6.
1.
Ma Y, Yang W, Song M, et al. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br J Cancer. 2018;119(11):1436-1442. doi:10.1038/s41416-018-0314-4.
1.
Guasch-Ferré M, Ruiz-Canela M, Li J, et al. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk. J Clin Endocrinol Metab. 2019;104(5):1508-1519. doi:10.1210/jc.2018-01000.